Benet Pera Selected Research

FR 182877

1/2012

Cyclostreptin derivatives specifically target cellular tubulin and further map the paclitaxel site.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benet Pera Research Topics

Disease

6	Neoplasms (Cancer) 07/2016 - 08/2010
3	Lymphoma (Lymphomas) 02/2018 - 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2018
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 07/2016
1	Rhabdomyosarcoma 07/2016
1	Sarcoma (Soft Tissue Sarcoma) 07/2016
1	Osteosarcoma (Osteogenic Sarcoma) 07/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016
1	Leukemia 11/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2015

Drug/Important Bio-Agent (IBA)

3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2015 - 01/2012
2	Excipients (Suspending Agents)IBA 11/2015 - 08/2010
2	plocabulinIBA 04/2014 - 09/2013
1	Choline (Choline Chloride)IBA 02/2018
1	Lysine (L-Lysine)FDA Link 02/2018
1	PanobinostatIBA 02/2018
1	Histone Deacetylase InhibitorsIBA 02/2018
1	Antineoplastic Agents (Antineoplastics)IBA 02/2018
1	obatoclaxIBA 01/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 07/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2016
1	DNA (Deoxyribonucleic Acid)IBA 07/2016
1	Drug CombinationsIBA 07/2016
1	1- (3- ((2- (dimethylamino)ethyl)carbamoyl)phenyl)- 3- (4- (bis(2- chloroethyl)amino)phenyl)ureaIBA 07/2016
1	Azacitidine (5 Azacytidine)FDA Link 01/2016
1	Vorinostat FDA Link 01/2016
1	Decitabine FDA Link 01/2016
1	Pharmaceutical PreparationsIBA 11/2015
1	Adenosine Triphosphate (ATP)IBA 11/2015
1	AICA ribonucleotide (ZMP)IBA 11/2015
1	Proteins (Proteins, Gene)FDA Link 11/2015
1	TubulinIBA 04/2014
1	PM050489IBA 09/2013
1	FR 182877IBA 01/2012

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2017 - 11/2015
1	Therapeutics 01/2016